Amy Burroughs, M.B.A., is a distinguished leader in the pharmaceutical industry, currently serving as the Chief Executive Officer and Director at TERNS PHARMACEUTICALS INC. With an extensive background in biopharmaceuticals, Burroughs has earned a reputation for her strategic vision and operational expertise. She holds a Master of Business Administration degree, which has equipped her with the necessary skills to navigate the complex landscape of drug development and commercialization. Before joining TERNS PHARMACEUTICALS INC., Burroughs held several high-level positions at various biopharmaceutical companies, where she demonstrated a proven track record of driving growth and innovation. Her career highlights include successfully leading teams through the development and launch of multiple blockbuster drugs, which significantly contributed to the companies' revenue and market presence. Burroughs' ability to foster collaboration and align organizational goals with scientific advancements has been instrumental in her success. As the CEO and Director of TERNS PHARMACEUTICALS INC., Amy Burroughs plays a pivotal role in shaping the company's strategic direction and overseeing its operations. Under her leadership, TERNS PHARMACEUTICALS INC. has focused on advancing its pipeline of innovative therapies, particularly in the field of metabolic diseases. Burroughs' commitment to improving patient outcomes and her dedication to excellence continue to drive the company forward, positioning TERNS PHARMACEUTICALS INC. as a leader in the biopharmaceutical industry.